Clear Cell Renal Cell Carcinoma With Brain Metastases Treated With Complementary Ketogenic Metabolic Therapy: A Case Report
Loading...
Date
2025-05-28
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
A 65-year-old woman was first diagnosed in 2011 with stage III clear cell renal cell carcinoma (pT3aNxM0)
of the left kidney, managed successfully with radical nephrectomy. She remained disease-free for three
years. In 2014, she developed a metachronous stage III papillary thyroid carcinoma (T1N1M0), treated with
total thyroidectomy, nodal dissection, and adjuvant radioactive iodine therapy (100 mCi). In 2019, two
pulmonary lesions were detected in the left upper lobe. Biopsy confirmed metastatic clear cell carcinoma.
Due to intolerance to sunitinib, the patient was treated with pazopanib. By September 2022, she developed
four intracranial metastatic lesions, predominantly in the right frontal lobe and bilateral mesial temporal
lobes. A neurosurgeon performed a biopsy, confirming metastatic clear cell carcinoma. The patient
underwent whole-brain radiotherapy over five sessions and began treatment with nivolumab. After
receiving five cycles of immunotherapy, the patient experienced a seizure associated with edema around the
dominant lesion and neurological decline. She was treated with anticonvulsants and a short steroid course,
leading to functional recovery. We used this treatment for around 10 days and continued immunotherapy
and anticonvulsant therapy. In January 2023, ketogenic metabolic therapy (KMT) was initiated using a 3:1
ratio ketogenic supplement (KetoVie). Ketone levels and neurological status were closely monitored.
Upon confirmation of ketones in the urine or blood, therapy adjustments were made to optimize adherence.
By July 2023, the patient no longer required assistance for medical appointments, discontinued
anticonvulsant therapy, and retained full cognitive function. In January 2024, the patient maintained a
partial response, and dietary supplementation was stopped. This case highlights the potential role of KMT
as a safe and complementary approach in advanced clear cell renal cell carcinoma. KMT may enhance the
efficacy of immunotherapy and radiotherapy, contributing to improved progression-free survival and
neurological function without increasing toxicity.
Description
In this report, we share our experience with a patient who had brain metastasis secondary to clear cell renal
cell carcinoma, treated with a combination of TKI, immunotherapy, and KMT, yielding outstanding results
Keywords
aerobic glycolysis, brain metastasis, immunotherapy, ketogenic metabolic therapy, kydney cancer
Citation
Acevedo A, Zapata Laguado M (May 28, 2025) Clear Cell Renal Cell Carcinoma With Brain Metastases Treated With Complementary Ketogenic Metabolic Therapy: A Case Report. Cureus 17(5): e84962. doi:10.7759/cureus.84962